The U.S. Chamber of Commerce and other groups asked a federal court to stop the CFPB from looking for discriminatory behavior when conducting routine examinations of financial firms.
Eisai and Biogen said their experimental Alzheimer’s drug significantly slowed progression of the memory-robbing disease in a large study, bolstering the drug’s prospects of approval.
The Justice Department says internal company documents show the airlines’ partnership in the Northeast hurts competition, but the carriers say real-world evidence is in their favor.
Ford is asking a Georgia court for a new trial, after a jury reached a $1.7 billion verdict against the auto maker last month involving a truck rollover accident that left two people dead.
The fitness-products maker, which also makes Schwinn indoor bikes, said the sale is being considered as part of a broader review of strategic alternatives.